Focal adhesion kinase signaling and function in pancreatic cancer

Frontiers in Bioscience - Elite

Volumn 3 E, Issue 2, 2011, Pages 750-756

  Ucar, Deniz A ^a   Dang, Long H ^a   Hochwald, Steven N ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Focal Adhesion Kinase; Pancreatic Cancer; Review

Indexed keywords

1,2,4,5 BENZENETETRAAMINE TETRAHYDROCHLORIDE; ANGIOGENIC FACTOR; ANTINEOPLASTIC AGENT; CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; FOCAL ADHESION KINASE; GEMCITABINE; GROWTH FACTOR RECEPTOR; INTERLEUKIN 1ALPHA; K RAS PROTEIN; MATRIX METALLOPROTEINASE; MITOGEN ACTIVATED PROTEIN KINASE; PF 562271; PROTEIN KINASE B; PROTEIN P16; PROTEIN P53; SMAD4 PROTEIN; SMALL INTERFERING RNA; SOMATOMEDIN C RECEPTOR; UNCLASSIFIED DRUG;

ADVANCED CANCER; APOPTOSIS; ARTICLE; BREAST TUMOR; CANCER CELL; CANCER PROGNOSIS; CANCER RESISTANCE; CANCER SURVIVAL; CELL ADHESION; CELL PROLIFERATION; CELL VIABILITY; CHEMOSENSITIZATION; CHEMOTHERAPY INDUCED NAUSEA AND VOMITING; COLORECTAL TUMOR; DIARRHEA; DRUG DOSE COMPARISON; DRUG DOSE ESCALATION; DRUG SAFETY; DRUG TOLERABILITY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; GENE MUTATION; GENE OVEREXPRESSION; GENE SILENCING; HEAD AND NECK TUMOR; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG TUMOR; MULTIPLE CYCLE TREATMENT; NONHUMAN; ONCOGENE SRC; OVARY TUMOR; PANCREAS ADENOCARCINOMA; PANCREAS CANCER; PANCREAS TUMOR; PHASE 1 CLINICAL TRIAL (TOPIC); PROSTATE TUMOR; PROTEIN EXPRESSION; REGULATORY MECHANISM; SARCOMA; SIGNAL TRANSDUCTION; SOLID TUMOR; TUMOR VOLUME; DRUG ANTAGONISM; FEMALE; GENETICS; MALE; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW;

FEMALE; FOCAL ADHESION PROTEIN-TYROSINE KINASES; HUMANS; MALE; PANCREATIC NEOPLASMS; SIGNAL TRANSDUCTION;

EID: 79952750782     PISSN: 19450494     EISSN: 19450508     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. G. Kloppel, G. Bommer, K. Ruckert and G. Seifert: Intraductal proliferation in the pancreas and its relationship to human and experimental carcinogenesis. Virchows Arch A Pathol Anat Histol, 387(2), 221-33 (1980) (Pubitemid 10061036)
2. S. Kozuka, R. Sassa, T. Taki, K. Masamoto, S. Nagasawa, S. Saga, K. Hasegawa and M. Takeuchi: Relation of pancreatic duct hyperplasia to carcinoma. Cancer, 43(4), 1418-28 (1979) (Pubitemid 9180309)
3. P. M. Pour, S. Sayed and G. Sayed: Hyperplastic, preneoplastic and neoplastic lesions found in 83 human pancreases. Am J Clin Pathol, 77(2), 137-52 (1982) (Pubitemid 12162490)
4. T. Furukawa, R. Chiba, M. Kobari, S. Matsuno, H. Nagura and T. Takahashi: Varying grades of epithelial atypia in the pancreatic ducts of humans. Classification based on morphometry and multivariate analysis and correlated with positive reactions of carcinoembryonic antigen. Arch Pathol Lab Med, 118(3), 227-34 (1994) (Pubitemid 24093645)
5. C. Almoguera, D. Shibata, K. Forrester, J. Martin, N. Arnheim and M. Perucho: Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes. Cell, 53(4), 549-54 (1988)
6. H. M. Blanck, P. E. Tolbert and J. A. Hoppin: Patterns of genetic alterations in pancreatic cancer: a pooled analysis. Environ Mol Mutagen, 33(2), 111-22 (1999) (Pubitemid 29172232)
7. C. Caldas, S. A. Hahn, L. T. da Costa, M. S. Redston, M. Schutte, A. B. Seymour, C. L. Weinstein, R. H. Hruban, C. J. Yeo and S. E. Kern: Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma. Nat Genet, 8(1), 27-32 (1994) (Pubitemid 24274057)
8. E. H. Mahlamaki, M. Barlund, M. Tanner, L. Gorunova, M. Hoglund, R. Karhu and A. Kallioniemi: Frequent amplification of 8q24, 11q, 17q, and 20q-specific genes in pancreatic cancer. Genes Chromosomes Cancer, 35(4), 353-8 (2002) (Pubitemid 35246993)
9. I. Ischenko, M. Guba, M. Yezhelyev, A. Papyan, G. Schmid, T. Green, M. Fennell, K. W. Jauch and C. J. Bruns: Effect of Src kinase inhibition on metastasis and tumor angiogenesis in human pancreatic cancer. Angiogenesis, 10(3), 167-82 (2007) (Pubitemid 47305201)
10. M. S. Duxbury, H. Ito, M. J. Zinner, S. W. Ashley and E. E. Whang: Inhibition of SRC tyrosine kinase impairs inherent and acquired gemcitabine resistance in human pancreatic adenocarcinoma cells. Clin Cancer Res, 10(7), 2307-18 (2004) (Pubitemid 38445688)
11. K. Burridge, C. E. Turner and L. H. Romer: Tyrosine phosphorylation of paxillin and pp125FAK accompanies cell adhesion to extracellular matrix: a role in cytoskeletal assembly. J Cell Biol, 119(4), 893-903 (1992)
12. L. A. Cary and J. L. Guan: Focal adhesion kinase in integrin-mediated signaling. Front Biosci, 4, D102-13 (1999)
13. J. L. Guan and D. Shalloway: Regulation of focal adhesion-associated protein tyrosine kinase by both cellular adhesion and oncogenic transformation. Nature, 358(6388), 690-2 (1992)
14. L. J. Kornberg, H. S. Earp, C. E. Turner, C. Prockop and R. L. Juliano: Signal transduction by integrins: increased protein tyrosine phosphorylation caused by clustering of beta 1 integrins. Proc Natl Acad Sci U S A, 88(19), 8392-6 (1991) (Pubitemid 21915362)
15. M. D. Schaller, C. A. Borgman, B. S. Cobb, R. R. Vines, A. B. Reynolds and J. T. Parsons: pp125FAK a structurally distinctive protein-tyrosine kinase associated with focal adhesions. Proc Natl Acad Sci U S A, 89(11), 5192-6 (1992)
16. D. D. Schlaepfer and T. Hunter: Integrin signalling and tyrosine phosphorylation: just the FAKs? Trends Cell Biol, 8(4), 151-7 (1998) (Pubitemid 28142262)
17. D. D. Schlaepfer, K. C. Jones and T. Hunter: Multiple Grb2-mediated integrin-stimulated signaling pathways to ERK2/mitogen-activated protein kinase: summation of both c-Src- and focal adhesion kinase-initiated tyrosine phosphorylation events. Mol Cell Biol, 18(5), 2571-85 (1998) (Pubitemid 28183427)
18. S. M. Frisch, K. Vuori, E. Ruoslahti and P. Y. Chan-Hui: Control of adhesion-dependent cell survival by focal adhesion kinase. J Cell Biol, 134(3), 793-9 (1996) (Pubitemid 26269148)
19. D. Ilic, E. A. Almeida, D. D. Schlaepfer, P. Dazin, S. Aizawa and C. H. Damsky: Extracellular matrix survival signals transduced by focal adhesion kinase suppress p53- mediated apoptosis. J Cell Biol, 143(2), 547-60 (1998) (Pubitemid 28487870)
20. L. A. Cary, J. F. Chang and J. L. Guan: Stimulation of cell migration by overexpression of focal adhesion kinase and its association with Src and Fyn. J Cell Sci, 109 ( Pt 7), 1787-94 (1996) (Pubitemid 26248624)
21. D. Ilic, S. Kanazawa, Y. Furuta, T. Yamamoto and S. Aizawa: Impairment of mobility in endodermal cells by FAK deficiency. Exp Cell Res, 222(2), 298-303 (1996) (Pubitemid 26045837)
22. V. Baron, V. Calleja, P. Ferrari, F. Alengrin and E. Van Obberghen: p125Fak focal adhesion kinase is a substrate for the insulin and insulin-like growth factor-I tyrosine kinase receptors. J Biol Chem, 273(12), 7162-8 (1998) (Pubitemid 28160390)
23. K. Furuyama, R. Doi, T. Mori, E. Toyoda, D. Ito, K. Kami, M. Koizumi, A. Kida, Y. Kawaguchi and K. Fujimoto: Clinical significance of focal adhesion kinase in resectable pancreatic cancer. World J Surg, 30(2), 219-26 (2006) (Pubitemid 43162494)
24. S. N. Hochwald, C. Nyberg, M. Zheng, D. Zheng, C. Wood, N. A. Massoll, A. Magis, D. Ostrov, W. G. Cance and V. M. Golubovskaya: A novel small molecule inhibitor of FAK decreases growth of human pancreatic cancer. Cell Cycle, 8(15), 2435-43 (2009)
25. W. Liu, D. A. Bloom, W. G. Cance, E. V. Kurenova, V. M. Golubovskaya and S. N. Hochwald: FAK and IGF-IR interact to provide survival signals in human pancreatic adenocarcinoma cells. Carcinogenesis, 29(6), 1096-107 (2008) (Pubitemid 351958687)
26. D. Zheng, V. Golubovskaya, E. Kurenova, C. Wood, N. A. Massoll, D. Ostrov, W. G. Cance and S. N. Hochwald: A novel strategy to inhibit FAK and IGF-1R decreases growth of pancreatic cancer xenografts. Mol Carcinog, 49(2), 200-9 (2010)
27. B. A. Siu LL, Mileshkin DR, Camidge D, Rischin EC, Chen S, Jones D, Yin H, Fingert: Phase 1 study of a focal adhesion kinase (FAK) inhibitor PF-00562271 in patients (pts) with advanced solid tumors. J Clin Oncol, 25(18S) (2007)
28. B. H. Dhani NC, Siu LL, Camidge DR, Mileshkin LR, Xu H, Pierce KJ, fahey NR, Fingert HJ, Shreeve SM: Final report of phase I clinical, pharmacokinectic (PK), pharmacodynamic (PD) study of PF-00562271 targeting focal adhesion kinase (FAK) in patients (pts) with solid tumors. J Clin Oncol, 28(15), 3028 (2010)
29. H. Sawai, Y. Okada, H. Funahashi, Y. Matsuo, H. Takahashi, H. Takeyama and T. Manabe: Activation of focal adhesion kinase enhances the adhesion and invasion of pancreatic cancer cells via extracellular signal-regulated kinase-1/2 signaling pathway activation. Mol Cancer, 4, 37 (2005)
30. D. Yamamoto, Y. Sonoda, M. Hasegawa, M. Funakoshi-Tago, E. Aizu-Yokota and T. Kasahara: FAK overexpression upregulates cyclin D3 and enhances cell proliferation via the PKC and PI3-kinase-Akt pathways. Cell Signal, 15(6), 575-83 (2003) (Pubitemid 36385163)
31. M. S. Duxbury, H. Ito, E. Benoit, M. J. Zinner, S. W. Ashley and E. E. Whang: RNA interference targeting focal adhesion kinase enhances pancreatic adenocarcinoma gemcitabine chemosensitivity. Biochem Biophys Res Commun, 311(3), 786-92 (2003) (Pubitemid 37377726)
32. M. S. Duxbury, H. Ito, M. J. Zinner, S. W. Ashley and E. E. Whang: Focal adhesion kinase gene silencing promotes anoikis and suppresses metastasis of human pancreatic adenocarcinoma cells. Surgery, 135(5), 555-62 (2004) (Pubitemid 38586530)
33. W. Huanwen, L. Zhiyong, S. Xiaohua, R. Xinyu, W. Kai and L. Tonghua: Intrinsic chemoresistance to gemcitabine is associated with constitutive and laminininduced phosphorylation of FAK in pancreatic cancer cell lines. Mol Cancer, 8, 125 (2009)
34. D. J. Sieg, C. R. Hauck, D. Ilic, C. K. Klingbeil, E. Schaefer, C. H. Damsky and D. D. Schlaepfer: FAK integrates growth-factor and integrin signals to promote cell migration. Nat Cell Biol, 2(5), 249-56 (2000)
35. D. Zheng, E. Kurenova, D. Ucar, V. Golubovskaya, A. Magis, D. Ostrov, W. G. Cance and S. N. Hochwald: Targeting of the protein interaction site between FAK and IGF-1R. Biochem Biophys Res Commun, 388(2), 301-5 (2009)
36. N. A. Chatzizacharias, C. Giaginis, D. Zizi-Serbetzoglou, G. P. Kouraklis, G. Karatzas and S. E. Theocharis: Evaluation of the clinical significance of focal adhesion kinase and SRC expression in human pancreatic ductal adenocarcinoma. Pancreas, 39(6), 930-6 (2010)
37. W. G. Roberts, E. Ung, P. Whalen, B. Cooper, C. Hulford, C. Autry, D. Richter, E. Emerson, J. Lin, J. Kath, K. Coleman, L. Yao, L. Martinez-Alsina, M. Lorenzen, M. Berliner, M. Luzzio, N. Patel, E. Schmitt, S. LaGreca, J. Jani, M. Wessel, E. Marr, M. Griffor and F. Vajdos: Antitumor activity and pharmacology of a selective focal adhesion kinase inhibitor, PF-562,271. Cancer Res, 68(6), 1935-44 (2008) (Pubitemid 351416580)